Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
(OP:
MDXXF
)
0.0498
UNCHANGED
Streaming Delayed Price
Updated: 10:01 AM EDT, Sep 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about MDXXF
PharmAla Launches MDMA Clinical Trial Tool for Researchers
August 22, 2024
From
PharmAla Biotech
Via
GlobeNewswire
PharmAla Comments on USFDA Decision regarding MDMA-Assisted Therapy and Announces Patent Granting for ALA-002
August 09, 2024
From
PharmAla Biotech
Via
GlobeNewswire
Cortexa Commences Manufacturing GMP LaNeo™ MDMA in Australia
April 05, 2024
Novel Composition of MDMA Enantiomers leading to next-generation MDMA possibilities
From
PharmAla Biotech
Via
GlobeNewswire
Patent Allowance Granted for ALA-002 Composition by US Patent and Trademark Office
March 27, 2024
Novel Composition of MDMA Enantiomers leading to next-generation MDMA possibilities
From
PharmAla Biotech
Via
GlobeNewswire
Patent Allowance Granted for P-1 Molecule by US Patent and Trademark Office
March 20, 2024
Novel MDMA-Like Drug Could Be Used for Numerous Neurological and Psychiatric Indications
From
PharmAla Biotech
Via
GlobeNewswire
Cortexa Leads the World in First Supply of Psilocybin Under the TGA’s Authorized Prescriber Scheme
March 18, 2024
PharmAla now first company to supply both MDMA and Psilocybin into the Australian Market
From
PharmAla Biotech
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.